Name | 2-fluoro-4-(1-methylimidazol-2-yl)aniline |
---|
Molecular Formula | C10H10FN3 |
---|---|
Molecular Weight | 191.20500 |
Exact Mass | 191.08600 |
PSA | 43.84000 |
LogP | 2.38960 |
~83% 218301-90-7 |
Literature: Bristol-Myers Squibb Pharma Company Patent: EP991638 B1, 2005 ; Location in patent: Page/Page column 54 ; |
~% 218301-90-7 |
Literature: Quan, Mimi L.; Lam, Patrick Y. S.; Han, Qi; Pinto, Donald J. P.; He, Ming Y.; Li, Renhua; Ellis, Christopher D.; Clark, Charles G.; Teleha, Christopher A.; Sun, Jung-Hui; Alexander, Richard S.; Bai, Steve; Luettgen, Joseph M.; Knabb, Robert M.; Wong, Pancras C.; Wexler, Ruth R. Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 1729 - 1744 |
~% 218301-90-7 |
Literature: Quan, Mimi L.; Lam, Patrick Y. S.; Han, Qi; Pinto, Donald J. P.; He, Ming Y.; Li, Renhua; Ellis, Christopher D.; Clark, Charles G.; Teleha, Christopher A.; Sun, Jung-Hui; Alexander, Richard S.; Bai, Steve; Luettgen, Joseph M.; Knabb, Robert M.; Wong, Pancras C.; Wexler, Ruth R. Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 1729 - 1744 |
Precursor 2 | |
---|---|
DownStream 0 |